Abstract
Invasive cancer cells utilize matrix metalloproteinases (MMPs) to degrade the extracellular matrix and basement membrane in the process of metastasis. Among multiple members of the MMP family, the gelatinase MMP-2 has been implicated in the development and dissemination of malignancies. However, the cellular source of MMP-2 and its effect on metastatic extravasation have not been well characterized. The objective of this study was to test the hypothesis that active MMP-2 derived from endothelial cells facilitated the transmigration of breast cancer cells across the microvascular barrier. Gelatin zymography was used to assess latent and active MMP-2 production in conditioned media from MDA-MB-231 human breast cancer cells, human lung microvascular endothelial cells (HLMVEC) and co-culture of these two cells. Transmigrated cancer cells were measured during MMP-2 knockdown with siRNA and pharmacological inhibition of MMP activity with OA-HY. The results showed consistent MMP-2 secretion by the HLMVECs, whereas a low level production was seen in the MDA-MB-231 cells. Inhibition of MMP-2 expression or activity in HLMVECs significantly attenuated the transmigration of MDA-MB-231 cells across an endothelial monolayer barrier grown on a reconstituted basement membrane. The data provide evidence supporting a potential role for the endothelial production of MMPs in promoting cancer cell extravasation. We suggest that the interaction between malignant cells and peritumoral benign tissues including the vascular endothelium may serve as an important mechanism in the regulation of tumor invasion and metastasis.
Similar content being viewed by others
References
Abeloff MD (2004) Cancer of the breast. In: Abeloff MD (ed) Clinical oncology, 3rd edn. Churchill Livingstone, New York
Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34
Foda HD, Zucker S (2001) Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. DDT 6:478–482
Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37–S43
Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activiates TGF-β and promotes tumor invasion and angiogenesis. Genes & Dev 14:163–176
Ata N, Oku T, Hattori M et al (1996) Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells. Oncol Res 8:503–511
Elkin M, Reich R, Nagler A et al (1999) Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. Clin Cancer Res 5:1982–1988
Zervos EE, Shafii AE, Hag M et al (1999) Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro. J Surg Res 84:162–167
Denkert C, Siegert A, Leciere A et al (2002) An inhibitor of stress-activated MAP-kinase reduces invasion and MMP-2 expression of malignant melanoma cells. Clin Exp Metastasis 19:79–85
Prontera C, Mariani B, Rossi C et al (1999) Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer 81:761–766
Nozaki S, Sissons S, Chien DS et al (2003) Activity of biphenyl matrix metalloproteinase inhibitor BAY 12–9566 in a human breast cancer orthotopic model. Clin Exp Metastasis 20:407–412
Yoneda T, Sasaki A, Dunstan C, et al (1997) Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphophonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99:2509–2517
Yuan SY (2000) Signal transduction pathways in enhanced microvascular permeability. Microcirc 7:395–403
Nicolson GL (1989) Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1:1009–1019
Emonard H, Marcq V, Mirand C et al (1999) Inhibition of gelatinase A by oleic acid. Ann NY Acad Sci 878:647–649
Xinbo Liao J, Thrasher B, Pelling J et al (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144:1656–1663
Tinsley JH, Breslin JW, Teasdale NR, Yuan SY. (2005) PKC-dependent, burn-induced adherens junction reorganization and barrier dysfunction in pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 289:L217–L223
Breslin JW, Yuan SY (2004) Involvement of RhoA, Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol 286:H1057–H1062
Jardines L, Callans LS, Torosian MH (1993) Recurrent breast cancer: presentation, diagnosis, and treatment. Semin Oncol 20:538–547
Tester AM, Waltham M, Oh SJ et al (2004) Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Res 64:652–658
Ko CH, Shen SC, Lee TJ et al (2005) Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4:281–290
Aye MM, Ma C, Lin H et al (2004) Ethanol-induced in vitro invasion of breast cancer cells: the contribution of mmp-2 by fibroblasts. Int J Cancer 112:738–746
Taylor PM, Woodfield RJ, Hodgkin MN et al (2002) Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipxygenase catalyzed pathway. Oncogene 21:5765–5772
Stark AM, Anuszkiewicz B, Mentlein R et al (2007) Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol 81:39–48
Szabo KA, Singh G (2005) Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells. Breast Cancer Res 7:R661–R668
McKerrow JH, Bharagava V, Hansell E et al (2000) A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 6:450–460
Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516
Hofmann UB, Eggert AAO, Blass K et al (2005) Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma. Arch Dermatol Res 297:154–160
Tang Y, Kesavan P, Nakada MT et al (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2:73–80
Caudroy S, Polette M, Nawrocki-Raby B et al (2002) EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19:697–702
Caudroy S, Polette M, Tournier JM et al (1999) Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. JHC 47:1575–1580
Strongin AY, Collier I, Bannikov G et al (1995) Mechanism of cell surface activation of 72-kDa Type IV collagenase. J Biol Chem 270:5331–5338
Jiang WG, Davies G, Martin TA et al (2006) Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17:583–590
Ueno H, Nakamura H, Inoue M et al (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57:2055–2060
Ellerbroek SM, Stack MS. (1999) Membrane associated matrix metalloproteinases in metastasis. BioEssays 21:940–949
Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M, Thompson EW (1997) MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15:111–120
Duffy MJ, Maguire TM, Hill A et al (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252–257
Voura EB, Sandig M, Siu CH (1998) Cell–cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 43:265–275
Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY (1999) Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 274:24930–24934
Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P, Xu W (2002) Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 90:1214–1221
Breslin JW, Sun H, Xu W, Rodarte C, Moy AB, Wu MH, Yuan SY (2006) Involvement of ROCK-mediated endothelial tension development in neutrophil stimulated microvascular leakage. Am J Physiol Heart Circ Physiol 290:H741–H750
Berton A, Rigot V, Huet E, Decarme M, Eeckhout Y, Patthy L, Godeau G, Hornebeck W, Bellon G, Emonard H (2001) Inovlovement of fibronecting type II repeats in the efficient inhibition of gelatinases A and B. J Biol Chem 276:20458–20465
Huet E, Cauchard JH, Berton A, Robinet A, Decarme M, Hornebeck W, Bellon G (2004) Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5. Biochem Pharmacol 67:643–654
Sidenius N, Blasi F (2003) The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22:205–222
Meehan WJ, Welch DR (2003) Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis 20:45–50
Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR (2004) Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 279:1562–1569
Acknowledgement
This work was supported by the NIH grants HL073324, HL061507, and HL084542.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kargozaran, H., Yuan, S.Y., Breslin, J.W. et al. A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24, 495–502 (2007). https://doi.org/10.1007/s10585-007-9086-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-007-9086-6